- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01401569
Efficacy of Exercise and Counseling Intervention on Relapse in Smoker With Depressive Disorders (STOB-ACTIV)
May 31, 2016 updated by: University Hospital, Montpellier
STOB-ACTIV: The Efficacy of Exercise and Counseling for Depressed Patients as an Aid for Smoking Cessation, a Randomized Controlled Trial
This study investigated the efficacy of an exercise and counseling intervention for depressed smokers (depression subscale of the Hospital Anxiety and Depression Scale, HADS-D score ≥ 8) in term of likelihood of smoking abstinence.
Participants were randomized to 8 weeks of intervention: individually delivered exercise and counseling (for smoking cessation and physical activity) or control: health education contact control condition.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This study investigated the efficacy of an exercise and counseling intervention for depressed smokers (depression subscale of the Hospital Anxiety and Depression Scale, HADS-D score ≥ 8) in term of likelihood of smoking abstinence.
Participants were randomized to 8 weeks of group delivered exercise and counseling (for smoking cessation and physical activity) or a health education contact control condition.
The investigators assess this intervention in a randomized controlled trial of 96 depressed adults smokers recruited by advertisements in local print allocated into one of the two groups (intervention group vs. control group) during a 8-week period and 3 follow-up visits (12, 24, 52 weeks after baseline).
All subjects (intervention and control groups) participate in a smoking cessation program composed of a pharmacological treatment (including nicotine replacement therapy or varenicline) and counseling.Experimental group subjects were required to attend 2 supervised exercise sessions and 2 counseling sessions during Week 1 and Week 2. Supervised exercise and counseling sessions are realized successively.
For Week 3 to 8, participants were required to attend 1 supervised exercise session and 1 counseling session plus 1 home exercise session.Supervized exercise session consist of 5-min warm-up, 30 min of aerobic activity (stationary bikes), and a 5-min cooldown with stretching.
The training intensity is of 60 to 80% maximum heart rate.
The sessions are supervised by an exercise specialist who verified and documented the heart rates.
Home exercise session consist of 45 min of aerobic exercise (walking, cycling, or running).
The training intensity is 6 to 7 on breathlessness visual analog scale.The smoking counseling sessions included the following components: review of a participant's smoking history and motivation to quit, help in the identification of high-risk situations, management of cigarette craving and the generation of problem-solving strategies to deal with such situations.Exercise counseling sessions designed to motivate increased regular physical activity and short bouts of exercise in response to negative affect and urges to smoke.
The goal of this intervention was to increase activity level.Health education group subjects were required to participate 75-minute supervised sessions with the same frequency of experimental group.
Participants in the health education condition received information on a variety of health topics including sleep hygiene, nutrition, stress and health screening tests for cancer prevention.
Participants were also asked to read handouts on health education topics covered during the session.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Montpellier, France, 34090
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages 18 to 65 years
- Must be able to give informed consent
- Must live in the area for the next 3 months
- Depression subscale of the Hospital Anxiety and Depression Scale, HADS-D score ≥ 8
- Fagerstrom score > 3
- Must be sedentary, have not participated regularly in aerobic physical exercise (for at least 20 minutes per day, 3 days per week) for the past six months.
- Must be able to exercise at 60% maximum heart rate (MHR) (cleared by a physician)
Exclusion Criteria:
- Cannot read or write fluently in the French language
- Pregnancy or plans to attempt pregnancy
- 60 minutes or more per week of moderate or vigorous physical activity
- Currently in a quit smoking program
- Currently using NRT of any kind or using any other quit smoking method or treatment
- Poor willingness or inability to comply with protocol requirements
Medical problems:
- Cancer treatment within the past 6 monthsPsychiatric Problems
- Currently suicidal or psychotic, (or suicidal/psychotic in last 6 months)
- Taking these specific medications for psychiatric problems: Mood stabilizer (Lithium, Depakote, Neurontin), Antipsychotics (Haldol, Clozaril, Risperdal)
- Currently diagnosis of a bipolar disorder as assessed by MINI 5.0
- Currently diagnosis of a alcohol dependence as assessed by MINI 5.0
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
All subjects (intervention and control groups) participate in a smoking cessation program composed of a pharmacological treatment (including nicotine replacement therapy or varenicline) and counseling.
|
Exercise and counseling (for smoking cessation and physical activity)
|
|
Experimental: physical activity program
Experimental group subjects were required to attend 2 supervised exercise sessions and 2 counseling sessions during Week 1 and Week 2. Supervised exercise and counseling sessions are realized successively.
For Week 3 to 8, participants were required to attend 1 supervised exercise session and 1 counseling session plus 1 home exercise session.
|
Exercise and counseling (for smoking cessation and physical activity)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of smoking cessation verified by expired air carbon monoxide
Time Frame: 12 weeks after baseline
|
To evaluate whether adding an established exercise and counseling intervention for depressed smokers to a standard smoking cessation treatment program improves smoking outcomes to 12 weeks after baseline ( 7-day point prevalence smoking abstinence verified by expired air carbon monoxide).
|
12 weeks after baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
prevalence smoking abstinence
Time Frame: (Baseline, 8, 12, 24, 52 weeks after baseline)
|
7-day point prevalence smoking abstinence verified by expired air carbon monoxide
|
(Baseline, 8, 12, 24, 52 weeks after baseline)
|
|
Evaluation of Anxiety and Depression
Time Frame: Baseline; 8, 12, 24, 52 weeks after baseline
|
The Anxiety and Depression are evaluated by the specific Scale (HADS)
|
Baseline; 8, 12, 24, 52 weeks after baseline
|
|
Physical Fitness/Activity
Time Frame: Baseline, 8 weeks 12, 24, 52 weeks after baseline
|
Physical Fitness/Activity are evaluated by the 6 minutes Walk Test or TDM6 (Time Frame: Baseline; 8weeks after baseline), by Accelerometry (Time Frame: Baseline; -1, 9 weeks), by the evaluation of Physical self esteem (Time Frame: Baseline; 8, 12 weeks after baseline)with a self-questionnaire (IPAQ7)
|
Baseline, 8 weeks 12, 24, 52 weeks after baseline
|
|
Evaluation of Weight
Time Frame: Baseline; 8,12, 24, 52 weeks after baseline
|
Baseline; 8,12, 24, 52 weeks after baseline
|
|
|
Evaluation of quality of life
Time Frame: Baseline; 8, 12 weeks after baseline
|
The quality of life is evaluated by a self-questionnaire (SF-12)
|
Baseline; 8, 12 weeks after baseline
|
|
Cigarette Craving
Time Frame: Baseline; 8, 12 weeks after baseline
|
The Cigarette Craving is evaluated by self-questionnaires: QSU and Fagerström test
|
Baseline; 8, 12 weeks after baseline
|
|
Smoking Abstinence self Efficacy
Time Frame: Baseline; 8, 12 weeks after baseline
|
The Smoking Abstinence self Efficacy is evaluated by the self-questionnaire (CSQ 12)
|
Baseline; 8, 12 weeks after baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, Lycett D, Jones LL, Kudlek L, Heath L, Hajizadeh A, Schenkels M, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD006219. doi: 10.1002/14651858.CD006219.pub4.
- Bernard P, Ninot G, Cyprien F, Courtet P, Guillaume S, Georgescu V, Picot MC, Taylor A, Quantin X. Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial. J Dual Diagn. 2015;11(3-4):205-16. doi: 10.1080/15504263.2015.1113842.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
July 21, 2011
First Submitted That Met QC Criteria
July 22, 2011
First Posted (Estimate)
July 25, 2011
Study Record Updates
Last Update Posted (Estimate)
June 1, 2016
Last Update Submitted That Met QC Criteria
May 31, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8608
- n°ID RCB 2010-A00119-30 (Other Identifier: Afssaps - French Health Products Safety Agency)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Exercise and counseling (for smoking cessation and physical activity)
-
Herlev and Gentofte HospitalRecruitingRenal Cancer | Renal Cell Cancer | Prehabilitation | Stage I Renal Cell Cancer | Kidney Cancers | Elderly (people Aged 65 or More)Denmark
-
Butler HospitalNational Institute on Drug Abuse (NIDA)Completed
-
Hospital de SabadellBristol-Myers SquibbUnknownSmoking | Hypertension | Diabetes Mellitus | Peripheral Arterial Disease | HypercholesterolemiaSpain
-
Oregon Research InstituteNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Coronary Disease | Diabetes Mellitus, Non-insulin Dependent | Coronary Heart Disease Risk Reduction
-
Duke UniversityNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
White River Junction Veterans Affairs Medical CenterNormaTec Industries LPUnknownIntermittent ClaudicationUnited States
-
University of BernUniversity of Zurich; Swiss National Science Foundation; University of Lausanne; University of Geneva, Switzerland and other collaboratorsCompleted
-
University of BernSwiss National Science Foundation; Bernese Lung League; Clinical Trial Unit Grant...CompletedSmoking Cessation | Pulmonary DiseaseSwitzerland
-
University of BernUniversity of Zurich; Swiss National Science Foundation; University of Lausanne; University of Geneva, Switzerland and other collaboratorsCompletedSmoking Cessation | ToxicitySwitzerland
-
University of BernUniversity of Zurich; Swiss National Science Foundation; University of Lausanne; University of Geneva, Switzerland and other collaboratorsCompleted